APC and neoplasm: Indeed, chromosomal translocations that increase RSPO expression, or mutations that block ZNRF3/RNF43-mediated ubiquitination and degradation of FZDs, augment Wnt signalling in APC-proficient tumours that therefore, crucially, retain ligand-dependence [282,342,343,344,345,346,347].